View Press Releases
-
GHO Capital acquires Ardena
GHENT, BELGIË - Jan 9, 2020 - London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing management team has acquired Ardena, a specialist contract development and manufacturing organization (CDMO) focused on early phase drug development, from Mentha Capital
Jan 13, 2020
-
Rho partners with TRI to provide centralized and risk-based quality management technology to their clients
DURHAM, NC - Jan 13, 2020 - For Immediate ReleaseRho partners with TRI to provide centralized and risk-based quality management technology to their clients Research Triangle Park, NC - January 13, 2020 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that it has partnered with Triumph Research Intelligence (TRI), a global leader in centralized and risk-based quality management (RBQM) technology
Jan 13, 2020
-
Aquestive Therapeutics Receives FDA Response to Citizen’s Petition
NEW YORK, NY, UNITED STATES - Jan 13, 2020 - Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients unmet needs and solve therapeutic problems, today reported that the U
Jan 13, 2020
-
Creative Biolabs Provides Anti-Human CXCL12 Therapeutic Antibody for Research Use
SHIRLEY, NY - Jan 12, 2020 - January 12, 2020, Creative Biolabs, as a leading supplier in the recombinant antibody (rAb) discovery and manufacturing, announced the newly-developed product CXCL12 for research use
Jan 11, 2020
-
Sano Genetics Deploys Lifebit CloudOS, Delivers Free Genotype Imputation for Direct to Consumer (DTC) Genetics Customers
LONDON, UK - Jan 9, 2020 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, and Sano Genetics, the biotech company that connects people with research studies, announced today the deployment of Lifebit CloudOS to power the Sano Genetics platform, achieving 35% increase in speed of imputation analyses with data security guaranteed
Jan 9, 2020
-
Kyruus Raises $42 Million in New Financing After Delivering Another Year of Record Growth
BOSTON, MA, UNITED STATES - Jan 8, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that it raised $42 million in new financing in a Series D round that brings its total funding to more than $125 million since its founding in 2010
Jan 8, 2020
-
MDI Biological Scientists Identify Pathways That Extend Lifespan by 500%
BAR HARBOR, ME, UNITED STATES - Jan 8, 2020 - Scientists at the MDI Biological Laboratory, in collaboration with scientists from the Buck Institute for Research on Aging in Novato, Calif
Jan 8, 2020
-
Certara Partners with Galderma in Advancing Modeling and Simulation Technology to Attain FDA Approval of AKLIEF® Topical Acne Cream
PRINCETON, NJ - Jan 8, 2020 - Certara®, the global model-informed drug development and decision support leader, today announced that its Simcyp® Population-based Simulator was used to support Jan 8, 2020
-
30 Health Systems Take United Action to Treat Substance Use Disorder and Addiction
CHICAGO, IL, UNITED STATES - Jan 7, 2020 - CHICAGO - January 7, 2020 - In response to the national opioid epidemic and the prevalence of other Substance Use Disorders (SUD) in the U
Jan 7, 2020
-
Absolute Antibody Launches VivopureX™ Recombinant Antibodies for In Vivo Research
REDCAR, UNITED KINGDOM - Jan 7, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models
Jan 7, 2020
-
Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use
PHILADELPHIA, PA - Jan 7, 2020 - Signant Health announced today a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Healths digital health platform for asthma and COPD (chronic obstructive pulmonary disease)
Jan 7, 2020
-
Quantum Dot Display Market Resurgent on Back of Strong Growth of Consumer Electronics Industry, Finds Fact.MR
DUBLIN, IRELAND - Jan 6, 2020 - Exponential growth in demand for high definition display panels for electronic devices is powering the quantum dot display market ahead, with growth pegged at an astounding CAGR of over 30% during the forecast period (2019 - 2027)
Jan 6, 2020
-
VERICHEM LABORATORIES OFFERS NIST TRACEABLE, LIQUID STABLE, STANDARD KIT FOR URINE URIC ACID TESTING
PROVIDENCE, NY - Jan 5, 2020 - A ready-to-use, liquid stable standard kit for Urine Uric Acid testing is now available from VERICHEM LABORATORIES
Jan 5, 2020
-
Improved data analysis with new Qlucore Omics Explorer V3.6
GUILDFORD, UNITED KINGDOM - Jan 2, 2020 - Qlucore Omics Explorer (QOE) supports the user with fast, simple and visual analysis of measured data from a wide range of sources and instruments to maximize the output of the analysis
Jan 2, 2020
-
BOC Sciences Launches Peptide Bioconjugation Service for Chemical Research, Diagnostics, and Therapeutic Industry
SHIRLEY, NY, UNITED STATES - Jan 2, 2020 - Earlier this month, BOC Sciences announced to launch its peptide bioconjugation service for researchers involved with medicinal chemistry, diagnostics and therapeutic study
Jan 1, 2020
-
Creative Peptides Launches synthetic peptide APIs for Drug Discovery and Development
LONG ISLAND CITY, NY, UNITED STATES - Jan 2, 2020 - Earlier this month, Creative Peptides, one of the worlds leading peptide experts, announced to launch its synthetic peptide APIs for both researchers and manufacturers who are involved in the field of drug discovery and development
Jan 1, 2020
-
MDI Biological Laboratory to Expand Innovative Data Literacy Program
BAR HARBOR, ME, UNITED STATES - Dec 31, 2019 - The MDI Biological Laboratory has announced that it is expanding its innovative SEPA (Science Education Partnership Award) program, which aims to improve secondary school education in data literacy while addressing the public health threat posed by arsenic in well water
Dec 31, 2019
-
X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor in Combination with Ibrutinib for the Treatment of Waldenström’s Macroglobulinemia (WM)
CAMBRIDGE, MA, UNITED STATES - Dec 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of a Phase 1b clinical trial of mavorixafor (X4P-001) in combination with ibrutinib (Imbruvica®) for the treatment of Waldenströms macroglobulinemia (WM), a rare form of non-Hodgkins lymphoma
Dec 30, 2019
-
Creative Diagnostics Launches Hepatitis B Virus Surface Antigen Mutants for Bio-research
SHIRLEY, NY - Dec 31, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently announced the launch of Hepatitis B Virus Surface Antigen Mutants manufacture platform using Yeast expression system
Dec 28, 2019
-
Everest Medicines Announces Approval of Nefecon’s Clinical Trial Application by the China National Medical Products Administration
NEW YORK, NY - Dec 18, 2019 - Shanghai, China – December 18, 2019 – Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced it has received Clinical Trial Application (CTA) approval from the China National Medical Products Administration to conduct clinical trials for Nefecon in China
Dec 18, 2019